SS
MGNX icon

SBI Securities’s MacroGenics MGNX Stock Holding History

SBI Securities’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5 Hold
1
– – ﹤0.01% 3983
2026
Q1 		$3 Sell
1
-58
-98% -$124 ﹤0.01% 3945
2025
Q4 		$95 Sell
59
-3,000
-98% -$4.72K ﹤0.01% 3422
2025
Q3 		$5.14K Hold
3,059
– – ﹤0.01% 2034
2025
Q2 		$3.7K Buy
3,059
+16
+0.5% +$23 ﹤0.01% 2130
2025
Q1 		$3.87K Buy
3,043
+12
+0.4% +$31 ﹤0.01% 2002
2024
Q4 		$9.85K Buy
+3,031
New +$10.9K ﹤0.01% 1656

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

SBI Securities's MGNX Position: Q2 2026 in Review

SBI Securities held its MacroGenics (MGNX) position steady in Q2 2026 at 1 share worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #3983.

SBI Securities first reported a position in MGNX in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.85K in Q4 2024. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • SBI Securities held 1 share of MacroGenics worth $5 as of Q2 2026.
  • SBI Securities left its MacroGenics share count unchanged in Q2 2026.
  • MacroGenics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3983 holding.
  • SBI Securities first reported a position in MacroGenics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's MacroGenics position peaked at $9.85K in Q4 2024.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.